Gerard P. De Leon

FDA investigator

Appears on 9 documents from 2015 to 2017, mostly at sites in Washington. Most often cites control of microbiological contamination (21 CFR 211.113).

9
Documents on file
5.7
Observations per 483
2015
First seen
2017
Most recent

What they cite most

From 38 observations

Activity by year

2015: 2, 2016: 3, 2017: 4

Where

Washington 6 · Idaho 2 · Oregon 1

Is Gerard P. De Leon coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

9 documents, newest first
FirmOpen
483 Kelley-Ross Compounding PharmacyAug 29, 2017 · Seattle, Washington
483 Kelley-Ross Compounding PharmacyAug 2, 2017 · Seattle, Washington
Response RAM Pharma, Inc.Mar 22, 2017 · Idaho Falls, Idaho
483 RAM Pharma, IncFeb 7, 2017 · Idaho Falls, Idaho
483 Form 483 · FEI 3007500366Dec 16, 2016 · Spokane, Washington
Response University of Washington Medical Center Inpatient PharmacyAug 24, 2016 · Seattle, Washington
483 Ballard Plaza Pharmacy I, Inc.Jun 10, 2016 · Seattle, Washington

About this profile

What does Gerard P. De Leon inspect?

Gerard P. De Leon appears on 9 documents on file covering 7 sites, mostly in Washington.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.42 and 21 CFR 211.67.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Gerard P. De Leon is dated Aug 29, 2017.